Endometriosis is a chronic (long-term) condition that causes inflammation. Tissue similar to the lining of the uterus (womb) grows outside it. It can cause severe pelvic pain, painful periods, pain during sex, bowel and bladder symptoms, fatigue and difficulty getting pregnant. Its cause is not well understood, and there is no cure.
It is common. Around 1 in 7 Australian women born in the mid-1970s had been diagnosed by their late 40s [1], and it is the third leading cause of non-fatal disease burden (the health lost to living with illness) among female reproductive and maternal conditions [1]. Because periods are widely expected to hurt, the pain is often normalised by patients, families and clinicians alike, and the road to a diagnosis can be long.
How long depends on where you start the clock. A 2025 study of Australian GP records found a median (the middle value) of 2.5 years between the first symptom a GP noted and a recorded diagnosis [2]. The figure of about 8 years, often quoted, measures from when symptoms first appear, including the years before someone first seeks help [2]. Both are true: the GP-records figure shows what happens once a woman is in the system, and the longer figure shows how much time passes before she gets there.
1 in 7
2.5 years
~8 years
+23%
71%
Why it matters in Australia
Endometriosis is becoming more visible in Australian health data. The share of women with a diagnosis recorded in general practice rose from 1.78 to 2.86 in every 100 between 2011 and 2021 [2], and hospitalisations have risen far faster than hospital use overall [3]. Some of this is likely better recognition, which is progress. Some of it is unmet need: emergency admissions for endometriosis rose from 7.8% to about 10% of endometriosis hospitalisations over the decade [3].
Who can pay matters. Seven in ten endometriosis procedures now happen in private hospitals [3], which raises questions about access for people without private insurance or in regional areas. Since 2018 Australia has had a National Action Plan for Endometriosis [6]. The federal government has also funded specialised endometriosis and pelvic pain clinics in general practice; 11 more were funded in 2025–26, bringing the total to 33 [5]. In May 2025 a newer hormonal treatment, Ryeqo, was listed on the PBS. More than 8,500 women have since used it, at a fraction of its previous cost of around $2,700 a year [4].
Global context
Endometriosis is a global condition. The World Health Organization estimates it affects about 10% of women of reproductive age worldwide, around 190 million people, and that there is still no cure. WHO also notes that many knowledge gaps remain, including the need for non-invasive ways to diagnose it and for medical treatments that don’t prevent pregnancy [7].
Sources
- Endometriosis. Australian Institute of Health and Welfare, 2025.
- The clinical presentation, investigation, and management of women diagnosed with endometriosis in Australian general practices, 2011–2021: an open cohort study (Mazza D et al.). Medical Journal of Australia, 223(11), 2025.
- Endometriosis hospital procedures. Australian Institute of Health and Welfare, 2026.
- One year on: millions saved on cheaper medicines for Australian women (media release). Australian Government, Minister for Women, 2026.
- Australian Government invests in women's health – key budget highlights. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2025.
- Why Australia needs a second National Action Plan for endometriosis (opinion; Ng C, Mishra G, Montgomery G, Abbott J). InSight+, Medical Journal of Australia, 2024.
- Endometriosis (fact sheet). World Health Organization, 2025.
Last reviewed: